These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23277395)

  • 1. Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer.
    Forma E; Brzeziańska E; Krześlak A; Chwatko G; Jóźwiak P; Szymczyk A; Smolarz B; Romanowicz-Makowska H; Różański W; Bryś M
    Mol Biol Rep; 2013 May; 40(5):3493-502. PubMed ID: 23277395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase IIβ binding protein 1 c.*229C>T (rs115160714) gene polymorphism and endometrial cancer risk.
    Forma E; Wójcik-Krowiranda K; Jóźwiak P; Szymczyk A; Bieńkiewicz A; Bryś M; Krześlak A
    Pathol Oncol Res; 2014 Jul; 20(3):597-602. PubMed ID: 24346708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.
    Starska K; Forma E; Nowacka-Zawisza M; Lewy-Trenda I; Ciesielski P; Pietruszewska W; Skóra M; Bryś M
    Tumour Biol; 2016 Apr; 37(4):4541-57. PubMed ID: 26503213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of TopBP1 in hereditary breast cancer.
    Forma E; Krzeslak A; Bernaciak M; Romanowicz-Makowska H; Brys M
    Mol Biol Rep; 2012 Jul; 39(7):7795-804. PubMed ID: 22544570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer.
    Karppinen SM; Erkko H; Reini K; Pospiech H; Heikkinen K; Rapakko K; Syväoja JE; Winqvist R
    Eur J Cancer; 2006 Oct; 42(15):2647-52. PubMed ID: 16930991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population.
    Mir R; Javid J; Al Balawi IA; Alkharsah KR; Hadi MA; Rahman MA; Hamoud E; Al Alawi Y; Al Zahrani ABM; Abu-Duhier FM
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):859-866. PubMed ID: 29582646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.
    Bagheri F; Mesrian Tanha H; Mojtabavi Naeini M; Ghaedi K; Azadeh M
    Mol Med Rep; 2016 May; 13(5):4494-8. PubMed ID: 27035115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study.
    Blaut MA; Bogdanova NV; Bremer M; Karstens JH; Hillemanns P; Dörk T
    J Negat Results Biomed; 2010 Nov; 9():9. PubMed ID: 21108795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
    Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
    Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer.
    Liu K; Bellam N; Lin HY; Wang B; Stockard CR; Grizzle WE; Lin WC
    Mol Cell Biol; 2009 May; 29(10):2673-93. PubMed ID: 19289498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 811 C/T polymorphism in the 3' untranslated region of the selenoprotein 15-kDa (Sep15) gene and breast cancer in Caucasian women.
    Watrowski R; Castillo-Tong DC; Fabjani G; Schuster E; Fischer M; Zeillinger R
    Tumour Biol; 2016 Jan; 37(1):1009-15. PubMed ID: 26264612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families.
    Hollestelle A; Pelletier C; Hooning M; Crepin E; Schutte M; Look M; Collee JM; Nieuwlaat A; Dorssers LC; Seynaeve C; Aulchenko YS; Martens JW; van den Ouweland AM; Weidhaas JB
    Breast Cancer Res Treat; 2011 Jul; 128(1):79-84. PubMed ID: 20676756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular basis of gynecological oncology--TopBP1 protein and its participation in the transcription process].
    Forma E; Wójcik-Krowiranda K; Bieńkiewicz A; Bryś M
    Ginekol Pol; 2012 May; 83(5):363-7. PubMed ID: 22708334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
    Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
    Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations.
    Jiang L; Deng J; Zhu X; Zheng J; You Y; Li N; Wu H; Lu J; Zhou Y
    Breast Cancer Res; 2012 Jul; 14(4):R105. PubMed ID: 22788972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TopBP1 promotes malignant progression and correlates with poor prognosis in osteosarcoma.
    Wu DP; Yan XB; Liu LG; Tian C; Han K; Zhang H; Min DL
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4022-4031. PubMed ID: 29028101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
    Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
    BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
    Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESR1 single nucleotide polymorphism rs1062577 (c.*3804T>A) alters the susceptibility of breast cancer risk in Iranian population.
    Dehghan Z; Sadeghi S; Tabatabaeian H; Ghaedi K; Azadeh M; Fazilati M; Bagheri F
    Gene; 2017 May; 611():9-14. PubMed ID: 28216037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.